Erciyes University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Kayseri Turkey (1978)

Organization Overview

First Clinical Trial
2005
NCT01275638
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

AYSUN BADEM | erciyes univercity | erciyes univercity medicine faculty | erciyes üniversitesi | ErciyesUniversity | Erciyes University | Erciyes University, Faculty of Dentistry | Erciyes University Faculty of Health Sciences 38039 Kayseri / Turkey | Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP) | Erciyes University Medical Faculty | Erciyes University Medical Faculty Infectious Diseases Departmen | Erciyes University Medical Faculty, Medical Oncology Department, 38039 Kayseri, Turkey | Erciyes university medicine faculty | Erciyes University Research Fund | Erciyes University School of Medicine | Erciyes University School of Medicine Depatment of Endocrinology and Metabolism Kayseri TURKEY | Erciyes universty medicine faculty | Kayseri Education and Research Hospital | Kayseri Education and Research Hospital of Medicine | Kayseri Erciyes University | Kayseri Erciyes University Faculty of Medicine | Kayseri, Erciyes University School of Medicine Hospital, Department of Internal Medicine and Gastroenterology | Kayseri Training and Research Hospital | Pınar TEKİNSOY KARTIN | TC Erciyes University | TC Erciyes University Medical Faculty

Active Ingredients

Drugs in Phase 4 Trials (32)

amantadine (symmetrel) (1 trial)

atomoxetine (strattera) (1 trial)

beta-glucans (1 trial)

Dexketoprofen (4 trials)

dexmedetomidine (precedex) (14 trials)

drospirenone (Yasmin) (1 trial)

epinephrine (levophed) (1 trial)

esmolol (brevibloc) (1 trial)

estradiol (progynon depot) (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

genistein (1 trial)

indocyanine green (ic-green) (1 trial)

isotretinoin (Accutane) (1 trial)

ketamine (ketalar) (4 trials)

levobupivacaine (chirocaine) (7 trials)

lidocaine (xylocaine) (6 trials)

magnesium sulfate (Tis-U-Sol) (1 trial)

medroxyprogesterone (provera) (1 trial)

methylphenidate (ritalin) (1 trial)

morphine (1 trial)

prednisone (meticorten) (1 trial)

propofol (diprivan) (4 trials)

serum (5 trials)

sevoflurane (ultane) (1 trial)

sitagliptin (januvia) (1 trial)

sodium chloride (2 trials)

spironolactone (aldactone) (1 trial)

tenoxicam (1 trial)

tirofiban (aggrastat) (1 trial)

tranexamic acid (cyklokapron) (1 trial)

tromethamine (tham) (3 trials)

urea (2 trials)

Drugs in Phase 3 Trials (9)

acetylcysteine (mucomyst) (2 trials)

benzocaine (Orajel) (1 trial)

ethanol (1 trial)

goserelin (zoladex) (1 trial)

lansoprazole (prevacid) (1 trial)

levofloxacin (levaquin) (1 trial)

procaine benzylpenicillin (novocaine) (1 trial)

secukinumab (cosentyx) (1 trial)

wharton's jelly mesenchymal stem cells (2 trials)

Drugs in Phase 2 Trials (3)

erucov-vac (2 trials)

inactivated SARS-Cov-2 vaccine (1 trial)

stem cells (1 trial)

Drugs in Phase 1 Trials (5)

clobetasol (dermovate) (1 trial)

covid-19 specific t cell derived exosomes (1 trial)

kirim-kongo-vax (1 trial)

retinoic acid (1 trial)

salicylic acid (1 trial)

Drugs in Other Trials (21)

acetaminophen (tylenol) (1 trial)

barley (1 trial)

black mulberry (1 trial)

coffee (1 trial)

cow milk (1 trial)

diclofenac (voltaren) (1 trial)

fentanyl (Innovar) (1 trial)

frankincense (1 trial)

geranium (1 trial)

gum (1 trial)

lavandula angustifolia (1 trial)

lavender (1 trial)

meperidine (demerol) (1 trial)

mineral oil (1 trial)

mitomycin (mutamycin) (1 trial)

myrrha (commiphora myrrha) (1 trial)

origanum dictamnus l (1 trial)

pomegranate (1 trial)

rocuronium (zemuron) (1 trial)

Rosmarinus officinalis (1 trial)

sesame oil (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Attention Deficit Disorder with Hyperactivity (Phase 4)

Blood Loss, Surgical (Phase 4)

Breast Neoplasms (Phase 3)

Cardiomyopathies (Phase 4)

Cardiotoxicity (Phase 4)

Cognitive Dysfunction (Phase 4)

Coronavirus Infections (Phase 1)

Deafness (Phase 3)

Endometrial Hyperplasia (Phase 4)

Fever (Phase 1)

Hearing Loss (Phase 3)

Hemorrhage (Phase 4)

Hemorrhagic Fever, Crimean (Phase 1)

Hemorrhagic Fevers, Viral (Phase 1)

Hyperplasia (Phase 4)

Hypotension (Phase 4)

Kidney Diseases (Phase 4)

No-Reflow Phenomenon (Phase 4)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Pain, Postoperative (Phase 4)

Pneumonia (Phase 1)

Postoperative Complications (Phase 4)

Premature Birth (Phase 4)

Psoriasis (Phase 3)

Reflex, Abnormal (Phase 4)

Retinal Diseases (Phase 4)

Retinopathy of Prematurity (Phase 4)

Sepsis (Phase 4)

Severe Acute Respiratory Syndrome (Phase 1)

Strabismus (Phase 4)

Tinnitus (Phase 4)

Toxemia (Phase 4)

Virus Diseases (Phase 1)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 63
  • # of Trial APIs: 70